Ocytocine and Cerebral Activation in Relation With Attachement

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

April 9, 2015

Primary Completion Date

April 27, 2018

Study Completion Date

April 27, 2018

Conditions
Attachement Style
Interventions
DRUG

nasal oxytocin or placebo

nasal administration of oxytocin or palcebo 45 min befor fMRI session

DEVICE

fMRI

FMRI during emotional image visualization

BEHAVIORAL

Attachement scale interview (ASI)

this scale is used to determine the attachement style of each participant

BEHAVIORAL

psychometric scales

self adminstrated questionnaires which asses the level of anxiety (Spielberger State-trait anxiety interview-STAI), depression (Beck depression inventory-BDI) and alexithymia (Toronta Alexuthymia scale-TAS 20)

Trial Locations (1)

25030

CHU Besancon, Besançon

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Besancon

OTHER

NCT02847143 - Ocytocine and Cerebral Activation in Relation With Attachement | Biotech Hunter | Biotech Hunter